These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6534831)

  • 41. Interfacial communications in recombinant rabbit kidney pyruvate kinase.
    Friesen RH; Chin AJ; Ledman DW; Lee JC
    Biochemistry; 1998 Mar; 37(9):2949-60. PubMed ID: 9485447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IEF-microheterogeneity of human PK-R: applicability for prenatal diagnosis.
    Megow D; Krätschmer J; Jacobasch G
    Biomed Biochim Acta; 1990; 49(2-3):S305-8. PubMed ID: 2386519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human erythrocyte pyruvate kinase (L'/R-PK): production and characterization of a monoclonal antibody.
    Heinrichs M; Jacobasch G; Scheiner-Bobis K; Bertram S; Eigenbrodt E; Reinacher M
    Biomed Biochim Acta; 1987; 46(2-3):S223-8. PubMed ID: 3593302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study of human M2-type pyruvate kinases isolated from human leukocytes and erythrocytes of a patient with red cell pyruvate kinase hyperactivity.
    Kechemir D; Max-Audit I; Rosa R
    Enzyme; 1989; 41(3):121-30. PubMed ID: 2498076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
    Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
    Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnosis of genetically determined diseases].
    Jacobasch G; Kuckelkorn U; Gerth C; Megow D
    Z Med Lab Diagn; 1991; 32(3-4):134-40. PubMed ID: 1897289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The activity and kinetics of pyruvate kinase in hypoxic newborns.
    Narli N; Satar M; Kayrin L; Yapicioğlu H; Ozlü F; Budgayci R
    Pediatr Hematol Oncol; 2005; 22(7):567-73. PubMed ID: 16166049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mammalian pyruvate kinase hybrid isozymes: tissue distribution and physiological significance.
    Cardenas JM; Dyson RD
    J Exp Zool; 1978 Jun; 204(3):361-7. PubMed ID: 660140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours.
    Mazurek S
    Ernst Schering Found Symp Proc; 2007; (4):99-124. PubMed ID: 18811055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Normalisation of red blood cell pyruvate kinase in pyruvate kinase deficiency by riboflavin treatment.
    Staal GE; van Berkel TJ; Nijessen JG; Koster JF
    Clin Chim Acta; 1975 May; 60(3):323-7. PubMed ID: 1139778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The isoenzymes of pyruvate kinase in normal, hypothyroid and dysmature rats.
    Gali P
    Biomedicine; 1976 Sep; 25(7):268-71. PubMed ID: 990388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A modelling study of feedforward activation in human erythrocyte glycolysis.
    Bali M; Thomas SR
    C R Acad Sci III; 2001 Mar; 324(3):185-99. PubMed ID: 11291305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification of pyruvate kinase from human erythrocytes by immunoaffinity chromatography.
    Kuckelkorn U; Jacobasch G
    Biomed Biochim Acta; 1990; 49(2-3):S313-6. PubMed ID: 2386520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The regulatory principles of glycolysis in erythrocytes in vivo and in vitro. A minimal comprehensive model describing steady states, quasi-steady states and time-dependent processes.
    Rapoport TA; Heinrich R; Rapoport SM
    Biochem J; 1976 Feb; 154(2):449-69. PubMed ID: 132930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythrocyte enzyme activities in myelodysplastic syndromes: elevated pyruvate kinase activity.
    Tani K; Fujii H; Takahashi K; Kodo H; Asano S; Takaku F; Miwa S
    Am J Hematol; 1989 Feb; 30(2):97-103. PubMed ID: 2913762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of methylguanidine and guanidinosuccinic acid on pyruvate kinase activity in human red cells].
    Kopczyński Z; Dryl-Rydzyńska T; Baczyk K
    Pol Tyg Lek; 1990 Jul 2-9; 45(27-28):565-7. PubMed ID: 2287580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Red cell enzyme activities and properties of mutant pyruvate kinase after long-term storage of red cells in liquid nitrogen.
    Fujii H; Miwa S; Ishida Y; Oda E; Nakatsuji T; Miura Y
    Vox Sang; 1979; 36(6):362-6. PubMed ID: 494573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pyruvate kinase isozymes among human organs and blood cells.
    Etiemble J; Boivin P
    Enzyme; 1976; 21(4):296-303. PubMed ID: 939222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pyruvate kinase deficiency in dog and human erythrocytes: effects of energy depletion on cation composition and cellular hydration.
    Muller-Soyano A; Platt O; Glader BE
    Am J Hematol; 1986 Nov; 23(3):217-21. PubMed ID: 3766523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pyruvate kinase isoenzymes in the kidneys of rabbits with insular insufficiency].
    Dozhevnikova KA; Il'in VS
    Probl Endokrinol (Mosk); 1975; 21(2):78-81. PubMed ID: 1129247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.